Table 5 Cox multivariable analysis of patients and treatment variables associated with overall survival and recurrence free survival (n = 454).

Male gender

0.16

0.88–1.54

0.2891

Age (per year)

0.99

0.98–1.01

0.0741

HCV vs HBV

0.96

0.68–1.34

0.8118

NAFLD vs HBV

0.35

0.15–0.80

0.0134

NAFLD vs HCV

0.37

0.17–0.77

0.0034

African American

Ref

—

—

White

0.66

0.23–1.89

0.4379

Asian

0.74

0.26–2.05

0.5568

Hispanic

0.9

0.30–2.68

0.8478

Not Hispanic

1.52

0.39–5.86

0.5451

Chemotherapy

Ref

—

—

OLT (after year 2000)

0.08

0.04–0.17

<0.0001

OLT (before year 2000)

0.11

0.04–0.27

<0.0001

PEI

0.36

0.14–0.92

0.0338

Resection

0.15

0.08–0.29

<0.0001

RFA

0.16

0.08–0.30

<0.0001

TACE

0.45

0.26–0.79

0.0055

Supportive care

0.83

0.49–1.42

0.5

Male gender

1.12

0.90–1.51

0.245

Age (per year)

0.99

0.98–1.01

0.0626

Etiologies:

HCV vs HBV

1.08

0.78–1.49

0.6504

NAFLD vs HBV

0.69

0.39–1.39

0.3002

NAFLD vs HCV

0.64

0.34–1.20

0.163

African American

Ref

—

—

White

0.76

0.27–2.18

0.6104

Asian

0.91

0.33–2.53

8608

Hispanic

0.92

0.31–2.71

0.8734

Not Hispanic

0.84

0.24–2.93

0.7824

Chemotherapy

Ref

—

—

OLT (after year 2000)

0.09

0.05–0.17

<0.0001

OLT (before year 2000)

0.11

0.04–0.28

<0.0001

PEI

0.38

0.15–0.98

0.0461

Resection

0.24

0.14–0.44

<0.0001

RFA

0.28

0.16–0.51

<0.0001

TACE

0.54

0.31–0.93

0.0276

Supportive Care

0.75

0.43–1.26

0.2749